









Markets
/
Stocks
/
nasdaq-gmed
/

Globus Medical Inc

GMED

60.635USD

-1.025-1.66%

Market hours （ET）Quotes delayed by 15 min

8.19BMarket Cap

22.96P/E TTM



Globus Medical Inc

60.635

-1.025-1.66%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Globus Medical Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Globus Medical Inc's Score

Industry at a Glance

Industry Ranking

11 / 210

Overall Ranking

49 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 15 analysts

Buy

Current Rating

78.818

Target Price

+28.79%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Globus Medical Inc Highlights

StrengthsRisks

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 146.31% year-on-year.

Undervalued

The company’s latest PE is 23.51, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 118.37M shares, decreasing 5.75% quarter-over-quarter.

Held by Joel Greenblatt

Star Investor Joel Greenblatt holds 244.08K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 8.88, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 745.34M, representing a year-over-year increase of 18.37%, while its net profit experienced a year-over-year increase of 538.68%.

Score

Industry at a Glance

Previous score

8.88

Change



Financials

9.03

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.83

Key Metrics

Free cash flow

No Data

Globus Medical Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 7.35, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 23.51, which is 1443.33% below the recent high of 362.76 and 15.85% above the recent low of 19.78.

Score

Industry at a Glance

Previous score

7.35

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 11/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 7.20, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Globus Medical Inc is 78.00, with a high of 106.00 and a low of 64.00.

Score

Industry at a Glance

Previous score

7.20

Change

Support & Resistance

No Data

Analyst Rating

Based on 15 analysts

Buy

Current Rating

78.818

Target Price

+28.79%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Globus Medical Inc

GMED

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 8.90, which is higher than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 65.15 and the support level at 57.33, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.82

Change

0.08

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.149

Neutral

RSI(14)

55.990

Neutral

STOCH(KDJ)(9,3,3)

37.311

Neutral

ATR(14)

1.514

High Vlolatility

CCI(14)

-3.951

Neutral

Williams %R

44.333

Buy

TRIX(12,20)

0.267

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

61.090

Sell

MA10

61.890

Sell

MA20

60.593

Buy

MA50

59.353

Buy

MA100

58.362

Buy

MA200

66.022

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 105.10%, representing a quarter-over-quarter increase of 2.95%. The largest institutional shareholder is The Vanguard, holding a total of 10.68M shares, representing 9.49% of shares outstanding, with 0.63% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

10.68M

-1.84%

BlackRock Institutional Trust Company, N.A.

9.81M

-0.55%

Janus Henderson Investors

8.21M

+17.14%

Burgundy Asset Management Ltd.

3.48M

+24.26%

State Street Investment Management (US)

3.47M

-3.93%

JP Morgan Asset Management

3.15M

+28.93%

Sculptor Capital Management, Inc

2.76M

+31.91%

William Blair Investment Management, LLC

2.41M

+5.77%

Hawk Ridge Capital Management LP

2.12M

+26.38%

Geneva Capital Management LLC

2.08M

+13.59%

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 7.50, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.